New orphan drug designation, page-16

Not necessarily speed benefits unless you get an FDA priority review voucher, which can't be used for the MPS trial but may be applied for subsequent FDA trials that the company does. Given MPS is much later in the process than OA - wouldn't be able to be applied to this. Nothing has been approved yet, PAR would have applied for orphan status, FDA doesn't scan the worlds drug makers and say "oh you there, here you go". Either way, years off and a very small indication - I think people are clutching at straws here to find any near-term benefit in PAR as they have a fair bit of money invested. The only reason people are on here talking about PAR is to give it a pump because they own a few, or they work for the company. Feel sorry for the people which may have put in money above $4 after listening to a lot of this "research" which has been going on in these forums.